CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-08 | Merck & Co., Inc. 10% owner | Other acquisition | +7,942,314 | 7,942,314 | ||
| 2016-02-08 | Merck & Co., Inc. 10% owner | Conversion · Series A Preferred Shares | −18,518,519 | 0 | ||
| 2016-02-08 | Merck & Co., Inc. 10% owner | Conversion · Series A-2 Preferred Shares | −5,128,205 | 0 | ||
| 2016-02-08 | Hillhouse Capital Management, Ltd. 10% owner | Conversion | +30,626,779 | 30,626,779 | ||
| 2016-02-08 | Hillhouse Capital Management, Ltd. 10% owner | Purchase | +9,100,000 | 39,726,779 | ||
| 2016-02-08 | Hillhouse Capital Management, Ltd. 10% owner | Conversion · Series A Preferred Shares | +14,814,814 | 0 | ||
| 2016-02-08 | Hillhouse Capital Management, Ltd. 10% owner | Conversion · Series A-2 Preferred Shares | +15,811,965 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion | +4,382,118 | 4,382,118 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion | +44,572,171 | 44,572,171 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion | +582,747 | 582,747 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion | +1,912,167 | 6,294,285 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion | +26,292,961 | 70,865,132 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise | +238,850 | $0.68 | $161K | 6,533,135 |
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise | +2,296,890 | $0.68 | $1.6M | 73,162,022 |
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise | +56,853 | $0.68 | $38K | 639,600 |
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Purchase | +189,374 | $24.00 | $4.5M | 189,374 |
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Purchase | +1,723,306 | $24.00 | $41.4M | 1,723,306 |
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Preferred shares | −4,382,118 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Preferred shares | −44,572,171 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Preferred shares | −582,747 | 0 |
Page 122 of 123 · 2,455 trades